Rudolf Eugster
Chief Executive Officer bei IBL International GmbH
Profil
Rudolf Eugster is currently the Co-Managing Director at IBL International GmbH and Tecan Deutschland GmbH.
He previously worked as the Chairman-Supervisory Board at STRATEC SE, Chief Financial Officer at Tecan Group AG, and Chief Financial Officer at Isola Composites GmbH.
He also worked as the Head of Strategic Planning & Controlling at Novartis AG from 1993 to 1994.
Eugster received his undergraduate, graduate, and doctorate degrees from the Swiss Federal Institute of Technology.
Aktive Positionen von Rudolf Eugster
| Unternehmen | Position | Beginn |
|---|---|---|
IBL International GmbH
 IBL International GmbH Miscellaneous Commercial ServicesCommercial Services IBL International GmbH develops and produces products for the medical-diagnostics laboratories. The company provides research services in the fields of enzyme, radio and luminescence immunoassays. The firm provides products in the diagnostic fields of Endocrinology, Catecholamines, Neuroscience, Tumormarkers, Hypertension, Cytokines, Adhesion Molecules, Autoimmunity, Immunology and Infectious Diseases. IBL International was founded in 1983 and is headquartered in Hamburg, Germany. | Chief Executive Officer | - |
Tecan Deutschland GmbH
 Tecan Deutschland GmbH Medical SpecialtiesHealth Technology Part of Tecan Group AG, Tecan Deutschland GmbH develops, manufactures and distributes automated laboratory instruments and solutions. The private company is based in Crailsheim, Germany. The CEOs of the German company are Rudolf Eugster, Richard Edward Patterson. | Chief Executive Officer | - |
Ehemalige bekannte Positionen von Rudolf Eugster
| Unternehmen | Position | Ende |
|---|---|---|
| TECAN GROUP AG | Director of Finance/CFO | 01.03.2020 |
| Isola Composites GmbH | Director of Finance/CFO | 01.01.2002 |
| NOVARTIS AG | Corporate Officer/Principal | 01.01.1994 |
| STRATEC SE | Chairman | - |
Ausbildung von Rudolf Eugster
| Swiss Federal Institute of Technology | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| NOVARTIS AG | Health Technology |
| TECAN GROUP AG | Health Technology |
| STRATEC SE | Health Technology |
| Private Unternehmen | 3 |
|---|---|
IBL International GmbH
IBL International GmbH Miscellaneous Commercial ServicesCommercial Services IBL International GmbH develops and produces products for the medical-diagnostics laboratories. The company provides research services in the fields of enzyme, radio and luminescence immunoassays. The firm provides products in the diagnostic fields of Endocrinology, Catecholamines, Neuroscience, Tumormarkers, Hypertension, Cytokines, Adhesion Molecules, Autoimmunity, Immunology and Infectious Diseases. IBL International was founded in 1983 and is headquartered in Hamburg, Germany. | Commercial Services |
Tecan Deutschland GmbH
Tecan Deutschland GmbH Medical SpecialtiesHealth Technology Part of Tecan Group AG, Tecan Deutschland GmbH develops, manufactures and distributes automated laboratory instruments and solutions. The private company is based in Crailsheim, Germany. The CEOs of the German company are Rudolf Eugster, Richard Edward Patterson. | Health Technology |
| Isola Composites GmbH |
